Results 11 to 20 of about 8,443,463 (315)

Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection [PDF]

open access: yes, 2002
Although antiviral agents which block human immunodeficiency virus (HIV) replication can result in long-term suppression of viral loads to undetectable levels in plasma, long-term therapy fails to eradicate virus, which generally rebounds after a single ...
Ruiz, L   +9 more
core   +1 more source

Difference of geographic distributions of the Chinese patients with prion diseases in the permanent resident places and referring places

open access: yesPrion, 2022
Human prion diseases (PrDs) are a group of transmissible neurodegenerative diseases that can be clarified as sporadic, genetic and iatrogenic forms. In this study, we have analysed the time and geographic distributions of 2011 PrD cases diagnosed by ...
Kang Xiao   +7 more
doaj   +1 more source

Trends in detectable viral load by calendar year in the Australian HIV observational database [PDF]

open access: yes, 2011
Background Recent papers have suggested that expanded combination antiretroviral treatment (cART) through lower viral load may be a strategy to reduce HIV transmission at a population level.
Cooper, D.A.   +39 more
core   +1 more source

Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection. [PDF]

open access: yes, 2012
OBJECTIVES: The magnitude of HIV viral rebound following ART cessation has consequences for clinical outcome and onward transmission. We compared plasma viral load (pVL) rebound after stopping ART initiated in primary (PHI) and chronic HIV infection (CHI)
López-Diéguez, María   +83 more
core   +1 more source

Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity [PDF]

open access: yes, 2011
Cellular immune responses during acute Hepatitis C virus (HCV) and HIV infection are a known correlate of infection outcome. Viral adaptation to these responses via mutation(s) within CD8+ T-cell epitopes allows these viruses to subvert host immune ...
Paul Klenerman   +53 more
core   +3 more sources

HCV treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. [PDF]

open access: yes, 2013
UNLABELLED: Substantial reductions in hepatitis C virus (HCV) prevalence among people who inject drugs (PWID) cannot be achieved by harm reduction interventions such as needle exchange and opiate substitution therapy (OST) alone. Current HCV treatment is
Dillon, John   +40 more
core   +1 more source

Mammalian-adaptive mutation NP-Q357K in Eurasian H1N1 Swine Influenza viruses determines the virulence phenotype in mice

open access: yesEmerging Microbes and Infections, 2019
It has recently been proposed that the Eurasian avian-like H1N1 (EA H1N1) swine influenza virus (SIV) is one of the most likely zoonotic viruses to cause the next influenza pandemic.
Wenfei Zhu   +11 more
doaj   +1 more source

MELD Score as a Predictor of Treatment Response of ‘Difficult to Treat’ Chronic HCV Patients [PDF]

open access: yesAfro-Egyptian Journal of Infectious and Endemic Diseases, 2019
Background and study aim: The introduction of direct acting antiviral agents shifted the management of chronic hepatitis C virus (HCV) infection to a new level. Pretreatment predictors of benefit are needed to help the selection of patients for treatment.
Mahmoud Salim   +2 more
doaj   +1 more source

Treatment interruption and variation in tablet taking behaviour result in viral failure: a case-control study from Cape Town, South Africa. [PDF]

open access: yes, 2011
BACKGROUND: Understanding of the impact of non-structured treatment interruption (TI) and variation in tablet-taking on failure of first-line antiretroviral therapy (ART) is limited in a resource-poor setting.
Orrell, Catherine   +8 more
core   +1 more source

Application of α-Syn Real-Time Quaking-Induced Conversion for Brain and Skin Specimens of the Chinese Patients With Parkinson’s Disease

open access: yesFrontiers in Aging Neuroscience, 2022
The real-time quaking-induced conversion (RT-QuIC) assay has been developed and used as an in vitro diagnostic tool for Parkinson’s disease (PD). In this study, we established α-Syn RT-QuIC using recombinant human α-Syn as the substrate.
Dong-Dong Chen   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy